Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 017130

Expand all

HEPARIN SODIUM (HEPARIN SODIUM)
1,000 UNITS/ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 1,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017130
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHAMBERLIN PARENTERAL CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

HEPARIN SODIUM (HEPARIN SODIUM)
5,000 UNITS/ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 5,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017130
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHAMBERLIN PARENTERAL CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

HEPARIN SODIUM (HEPARIN SODIUM)
10,000 UNITS/ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017130
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHAMBERLIN PARENTERAL CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information

HEPARIN SODIUM (HEPARIN SODIUM)
20,000 UNITS/ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20,000 UNITS/ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N017130
Product Number: 004
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CHAMBERLIN PARENTERAL CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information